Kestra Medical Corp (KMTS) Enterprise Value to EBITDA Ratio

Kestra Medical Technologies management is focusing on the implementation of wearable monitoring systems for high-risk individuals. The company's EV/EBITDA ratio in a historical context demonstrates a turning point caused by competition with equipment behemoths and a reliance on external electronics assemblers. The advantage of KMTS is based on sensor accuracy and software integration, with the metric reaching the level of 0.00.

KMTS Kestra Medical Technologies, Inc.: Business Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/11/2026

Comprehensive metric breakdowns and analytics for kestramedical.com (KMTS)

- market price and analyst price targets:

Price Chart Kestra|KMTS - Analyst Median Target

- market capitalization details:

Market Valuation Kestra Medical Corp|KMTS - Aggregate Business Value

- business book valuation details:

Net Assets per Single Share Kestra Medical Technologies|KMTS - Accounting Value of Company|Market Capitalization to Book Value Ratio kestramedical.com|KMTS - Company Total Assets

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

KMTS - Net Financial Result|Projected Future Earnings Kestra Medical Technologies|KMTS - Price to Earnings Ratio|Forward P/E Multiple Kestra Medical Technologies|KMTS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kestra Medical Corp|KMTS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Kestra Medical Technologies|KMTS - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months kestramedical.com|KMTS - Net earnings per one share growth for the current year|Earnings growth forecast for next year Kestra Medical Technologies

Analysis of all company metrics:Kestra KMTS

An analysis of the EV/EBITDA dynamics for the capital-intensive Kestra Medical Technologies (KMTS) allows for an assessment of the entire business value relative to its operating profit before interest, taxes, depreciation, and amortization. This multiple is critically important for Kestra Medical Technologies, as it reflects the efficiency with which a young management team is scaling wearable devices amidst high debt pressure and an advance vote of confidence from investors.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Regeneron Inc. REGN|Total Company Value to Operating Income Before Depreciation Ratio iRhythm Corp (IRTC)|LNTH: Enterprise Value to EBITDA Ratio|mineralystx.com - Enterprise Value to Operating Income Before Depreciation Ratio|HeartFlow Corp (HTFL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Esperion Therapeutics, Inc. - Business Value to Operating Income Before Depreciation|AMRN (Amarin Corp) - EV/EBITDA Multiple|EV/EBITDA Multiple Anteris Technologies Ltd|Enterprise Value to EBITDA Ratio TNYA (Tenaya Therapeutics)|CVRX (cvrx.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Milestone Pharmaceuticals Inc. MIST|CRDL - Enterprise Value to EBITDA Ratio|HeartBeam Corp - EV/EBITDA Multiple|Company Value to EBITDA Tenax Therapeutics Inc|ADGM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation BCDA|VTAK (Catheter Precision, Inc.) - EV/EBITDA Multiple|ARCA Bio (ABIO) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ACST|Enterprise Value to EBITDA Ratio Aerovate Therapeutics, Inc AVTE|EV/EBITDA Multiple VERV (Verve Therapeutics, Inc.)|EV/EBITDA Multiple Windtree Therapeutics Inc. WINT